{"title":"EGFR inhibition and other targeted therapies in NSCLC","authors":"C. Langer","doi":"10.1016/J.CMONC.2012.08.009","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":72649,"journal":{"name":"Community oncology","volume":"9 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/J.CMONC.2012.08.009","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Community oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/J.CMONC.2012.08.009","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}